Retatrutide 40mg
$90.00
Sale price
$90.00
Regular price
Skip to product information
Retatrutide 40mg
$90.00
Sale price
$90.00
Regular price
Retatrutide is an investigational triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. It is currently under clinical evaluation and is available strictly for research purposes only.
Mechanism of Action
By activating three distinct hormone receptor pathways, Retatrutide modulates energy homeostasis, glucose metabolism, and lipid regulation. This multi-receptor approach differentiates it from single or dual agonist compounds.
Research Applications
- Metabolic and obesity research
- Glucose regulation studies
- Energy expenditure and lipid metabolism investigations
- Comparative receptor agonist studies
Important Notice
This product is intended for research use only. It is not approved by the FDA or any regulatory authority for human therapeutic use, consumption, or veterinary application. Not for human or animal use.